Skip to main content
Back to BlackRock

BlackRock's Life Science Portfolio

Browse 8 Life Science companies funded by BlackRock. See funding amounts, founder contacts, and investment details.

Life Science Companies
8
Total Funding in Life Science
$1.0B

Life Science Portfolio Companies (8)

Export
BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

South San Francisco, United States
July 2026
$50.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiotechnologyGeneticsLife Science

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Dallas, United States
June 2026
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePrecision MedicineTherapeutics

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Boulder, United States
March 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Allschwil, Switzerland
June 2024
$90.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceManufacturingMedicalTherapeutics

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

South San Francisco, United States
January 2026
$257.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Somerville, United States
October 2022
$121.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceMedical

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Solana Beach, United States
January 2021
$125.0M
Series B

Founder Contacts

41,000+ verified contacts

Explore BlackRock's Full Portfolio

View all companies funded by BlackRock across every industry and funding stage.

View Full BlackRock Portfolio